Molecular Targeting and Signal Transduction
Our limited understanding of cellular regulatory signal-transduction-networks has been a barrier to progress in improving the overall cure-rate of human cancers. Delineation of the physiologic roles of the specific regulatory signaling components, with known association with metastatic phenotypes, i...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Boston, MA :
Springer US,
2004.
|
Σειρά: | Cancer Treatment and Research,
119 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Biology of the Epidermal Growth Factor Receptor Family
- Integrin Signaling in Cancer
- Regulators of Vascular Endothelial Growth Factor Expression in Cancer
- Integrin-Linked Kinase (ILK) in Combination Molecular Targeting
- P21-Activated Kinase 1: An Emerging Therapeutic Target
- Basis and Importance of SRC as a Target in Cancer
- Therapeutic Targeting of the Receptor Tyrosine Kinase Met
- Nuclear Factor-?B Activation Mediates Cellular Transformation, Proliferation, Invasion Angiogenesis and Metastasis of Cancer
- The P53 Pathway: Targets for the Development of Novel Cancer Therapeutics
- Runx Protein Signaling in Human Cancers
- Signal Transduction Mediated by Cyclin D1: from Mitogens to Cell Proliferation: A Molecular Target with Therapeutic Potential
- Signal Transduction Pathways in BCR-ABL Transformed Cells
- Estrogen Receptors and Anti-Estrogen Therapies
- Targeting Endothelin Axis in Cancer
- km23: A Novel TGF? Signaling Target Altered in Ovarian Cancer.